By David | Biotech News Today
A biologic medicine is only as reliable as the process that makes it. Because living cells produce these drugs, even a small change in temperature, nutrients, or purification can change the final product. That is why process development and control sit at the centre of biopharmaceutical manufacturing. This guide explains what process development is, how formulation fits in, and how companies keep every batch consistent and safe.
What Is Process Development?
Process development is the work of designing, testing, and improving the method used to make a medicine. For a biologic, it answers practical questions: Which cells should make the protein? How should they be grown? How is the protein separated from everything else? What final mixture keeps it stable?
The goal is a process that is repeatable, scalable, and well controlled. A method that works once in a small lab flask is not enough. It must work again and again at larger scale, with the same quality each time. For an introduction to the manufacturing side, see our guide on how biologic drugs are made.
The Three Main Areas of Biopharma Process Development
| Area | What it covers | Key aim |
|---|---|---|
| Upstream | Cell line, growth medium, bioreactor conditions | High yield of a good-quality protein |
| Downstream | Harvest, purification, virus removal, concentration | Pure, safe, active product |
| Formulation and fill-finish | Final mixture, container, sterile filling | Stable product that is safe to inject |
Upstream Process Development
Upstream work covers everything up to the point where the cells have produced the protein. Developers choose a host cell, often a mammalian cell line such as Chinese hamster ovary (CHO) cells for antibodies, then tune the conditions in which the cells grow. Common factors include:
- Nutrient mix and feeding schedule
- Temperature and pH
- Dissolved oxygen
- Culture duration and harvest time
A better-optimised upstream process can raise the amount of product made and improve its quality.
Downstream Process Development
Downstream work separates the target protein from cells, leftover nutrients, and other impurities. Typical steps include filtration, several chromatography steps, steps that remove or inactivate viruses, and concentration. Each step is designed to remove a particular kind of impurity while keeping the protein intact.
Formulation Process Development Strategies
Formulation is the stage where the purified protein is placed into its final liquid or dry form. Proteins are delicate. They can clump together (aggregate), break apart, or lose activity if the surrounding mixture is not right. Good formulation protects the drug during storage, transport, and use.
Key formulation strategies used in biopharmaceutical manufacturing include:
- Choosing the buffer and pH. The right pH keeps the protein stable and comfortable for the patient.
- Adding stabilisers. Sugars and amino acids are commonly used to protect protein structure.
- Using surfactants. Small amounts reduce clumping caused by shaking or contact with surfaces.
- Choosing liquid or freeze-dried form. A freeze-dried (lyophilised) product can last longer but needs to be mixed before use.
- Managing concentration and thickness. Products given under the skin often need a high concentration, which can make the liquid thick and harder to inject.
- Selecting the container. Vials, prefilled syringes, and cartridges can all affect stability.
| Formulation choice | Benefit | Possible challenge |
|---|---|---|
| Liquid formulation | Ready to use, simple for patients | May have shorter shelf life |
| Freeze-dried formulation | Longer stability | Needs reconstitution before use |
| High-concentration formulation | Allows small injection volume | Thickness and clumping risks |
| Prefilled syringe | Convenient and reduces dosing errors | Needs compatible materials |
Stability studies test the formulation under different temperatures and time periods to show how long the product stays safe and effective.
What Is Process Control?
Process control means monitoring and managing the manufacturing process so that every batch meets the same quality standards. It includes setting limits, measuring results during production, and acting if something moves outside the planned range.
A few key terms help explain how it works:
| Term | Meaning |
|---|---|
| Critical Quality Attribute (CQA) | A property of the product that must stay within a limit to ensure quality, such as purity or potency |
| Critical Process Parameter (CPP) | A process setting that can affect a CQA, such as temperature or pH |
| Design space | The range of conditions shown to produce acceptable quality |
| Control strategy | The full set of controls that keeps the process and product within limits |
Quality by Design (QbD)
Modern biopharma development often follows the idea of Quality by Design. Instead of testing quality only at the end, developers build quality into the process from the start. They identify which product properties matter most, learn which process settings affect them, and then set controls around those settings.
This approach is supported by international guidelines from the International Council for Harmonisation (ICH), including the quality guidelines on pharmaceutical development and quality risk management (ICH: Quality Guidelines).
Process Validation
Before a medicine can be sold, the manufacturer must show that the process consistently produces the right product. The U.S. Food and Drug Administration describes process validation as the collection and evaluation of data, from process design through commercial production, that shows a process can deliver quality products (FDA: Process Validation guidance).
The guidance describes three stages:
- Process design. The commercial process is defined based on development knowledge.
- Process qualification. The process and facility are shown to work as intended.
- Continued process verification. Data is collected during routine production to confirm the process stays in control.
Tools That Support Process Control
Biopharma companies use several tools to stay in control:
- In-process testing. Samples are tested during production, not only at the end.
- Process analytical technology (PAT). Sensors and instruments measure key variables in real time.
- Statistical monitoring. Trends across many batches are tracked to catch small drifts early.
- Batch records and documentation. Every step is written down so it can be reviewed later.
- Change control. Any planned process change is assessed and approved before it is made.
Why Process Development Matters
Process development affects patient safety, supply, and cost. A well-designed process reduces failed batches, improves consistency, and helps a company move more smoothly from clinical trials to commercial supply. A poorly understood process can cause delays, shortages, or quality problems.
It also matters when work moves between sites. Companies that outsource development or manufacturing must transfer their process to partners, which depends on clear documentation and well-understood controls. You can read more in our guides on biologics development and outsourcing and what a CDMO is.
For background on the medicines themselves, see our article on biopharmaceuticals and how the industry compares with traditional drug making in biotech vs pharma.
Frequently Asked Questions
What is process development in biopharma? It is the work of designing and improving the method used to make a biologic so that it is consistent, scalable, and well controlled.
What is the difference between upstream and downstream processing? Upstream covers growing cells that make the protein. Downstream covers separating and purifying that protein.
Why is formulation important for biologics? Proteins are delicate, so the final mixture must keep them stable and safe during storage and use.
What is a critical quality attribute? It is a product property, such as purity or potency, that must stay within a set range to ensure quality.
What is process validation? It is the evidence, gathered across development and production, that a process consistently makes a product of the right quality.
Final Thoughts
Process development and control turn a scientific discovery into a reliable medicine. By designing upstream, downstream, and formulation steps carefully, and by monitoring them with clear controls, biopharma companies can deliver consistent products batch after batch. For students, this field offers strong career options in bioprocess engineering, analytical science, and quality.
This article is for educational purposes only and is not medical or investment advice.
Leave a Reply